Professor Nakatsuji is a graduate from Kyoto University. He obtained postdoctoral training in Sweden, USA and UK. He became a professor at National Institute of Genetics in 1991. In 1999, He moved to the Institute for Frontier Medical Sciences at Kyoto University and became its director from 2003 to 2007. His laboratory established monkey ES cell lines in 2000 and human ES cell lines in 2003, which were distributed to other scientists. He is also a scientific founder of a start-up company, ReproCELL, Inc., which accomplished successful IPO in 2013
From 2007, He is the founding director of Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS), an institute which aims to advance cross-disciplinary research and technological innovation, including stem cell R&D utilizing chemical compounds and functional materials. He became a Professor Emeritus of Kyoto University in 2015. He took a leadership in government-supported projects carried out by collaboration between technology-oriented companies and academic groups.
In 2014, he founded two start-up companies, Kyoto Stem Cell Innovation, Inc (SCI) and Stem Cell & Device Laboratory, Inc. (SCAD). He is a Director and Chief Advisor of SCI and SCAD. SCAD is aiming at development of innovative products by integration of stem cell technology and nanotechnology/micro-engineering, with a focus on human pluripotent stem cells (ES/iPS cells). It develops and supplies high quality cell and micro-tissue products for drug screening and drug safety assay as well as cell therapy.